<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23522316</identifier>
<setSpec>2444-054X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Carrillo-Córdova, Dulce María</dc:author>
<dc:author>Carrillo-Córdova, Jorge Raúl</dc:author>
<dc:author>Carrillo-Córdova, Carlos Alberto</dc:author>
<dc:author>Carrillo-Córdova, Luis Daniel</dc:author>
<dc:author>Carrillo-Esper, Raúl</dc:author>
<dc:author>Carrillo-Cortes, Ulises</dc:author>
<dc:description xml:lang="en">INTRODUCTION portal hypertension and variceal hemorrhage are common complications of hepatic cirrhosis, both associated with a high morbimortality. Portal system decompression by the placement of a transjugular intrahepatic portosystemic stented shunt, can reduce portal venus pressure and is effective controling complications of portal hypertension, like variceal hemorrhage and ascitis. The aim of this document is to describe a case of hemolytic anemia secondary to the placement of a transjugular intrahepatic portosystemic stented shunt. CLINICAL CASE patient with portal hypertension secondary to liver cirrosis was given a transjugular intrahepatic portosystemic stented shunt for recurrent variceal hemorrhage. After the procedure, hemoglobin decreased 2 g/dL, associated with reticulocitosis, hipohaptoglobinemia, elevated lactic dehydrogenase and indirect hyperbilirrubinemia with negative Coombs test. The peripheral blood smear showed abnormal erythrocytes, with the prevalence of schistocytes. The final diagnosis was hemolytic anemia secondary to transjugular intrahepatic portosystemic stented shunt. CONCLUSIONS the hemolytic anemia secondary to Transjugular Intrahepatic Portosystemic Stented Shunt is a rare complication. Usually, it has a benign prognosis, and it is self-limited once the stent is endothelialized.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:subject>portal hypertension</dc:subject>
<dc:subject>transjugular intrahepatic portosystemic stent shunt</dc:subject>
<dc:subject>crenocite</dc:subject>
<dc:subject>hemolytic anemia</dc:subject>
<dc:date>2013 Mar-Apr </dc:date>
<dc:title xml:lang="es">Anemia hemolítica secundaria a la colocación de Stent transyugular intrahepático porto sistémico.</dc:title>
<dc:title xml:lang="en">[Hemolytic anemia secondary to the placement of a portosystemic stented shunt].</dc:title>
<dc:publisher>Cirugia y cirujanos</dc:publisher>
</metadata>
</record>
</pubmed-document>
